XEROX | Material Safety Data Sheet | MSDS No: | |
|
| Date: | 8/14/85 |
|
| Revision: | 1/12/07 |
Supplier: Xerox Corporation | Xerox Canada Ltd. |
Rochester, NY 14644 | 5650 Yonge Street |
| North York, Ontario M2M 4G7 |
Telephone # (s): Safety Information: (800) 828-6571
Health Emergency:
Transportation Emergency (Chemtrec): (800) 424-9300
|
| Section I - Product Identification |
|
|
| ||
Trade Names/Synonyms: | ECP- Magenta Toner Premix/Concentrate for ECP 42 | Part No.: | 26R351 | ||||
Chemical Name: | None |
|
| 26R237 | |||
|
| 26R30 | |||||
WHMIS Status: | Class B/Div. 3, Combustible liquid and Class D/Div. 2B, Toxic | ||||||
26R236 | |||||||
|
|
|
|
|
| 26R238 | |
| Ingredients (% by wt.)1,2 |
| CAS No. |
| *Cancelled | ||
|
|
|
| ||||
|
|
|
|
|
|
| |
Isoparaffinic hydrocarbon solvent |
|
|
| ||||
Polymer (<2%) |
| Trade Secret 3 |
|
| |||
Pigment (<2%) |
| Trade Secret 3 |
|
| |||
|
| Section II - Emergency and First Aid |
|
| |||
Primary Route of Entry: |
|
| Symptoms of Overexposure: |
| |||
Inhalation |
|
| High vapor concentrations (>1000 ppm) are irritating to | ||||
Eyes: |
|
| the eyes and respiratory tract, and may cause headaches, | ||||
Flush with water for 15 minutes. If irritation persist, call a physician. | dizziness anesthesia, drowsiness, unconsciousness, and | ||||||
Skin: |
|
| other central nervous system effects, including fatality. | ||||
Wash with soap and water. If skin is broken, call a physician. |
|
|
|
| |||
Inhalation: |
|
| Medical Conditions Generally Aggravated by Exposure: | ||||
Remove from exposure. |
|
| Skin contact may aggravate an existing dermatitis. | ||||
Ingestion: |
|
|
|
|
|
| |
DO NOT induce vomiting, call a physician immediately. | Additional Information: |
|
| ||||
|
|
|
| None. |
|
|
|
Section III - Toxicology and Health Information
This material has been evaluated by Xerox Corporation. The toxicity data noted below is for isoparaffinic hydrocarbons and similar inks.
Oral LD50: | >10 g/kg (rat) practically | TLV: | N.E. |
Dermal LD50: | >3.2 g/kg (rabbit) practically | PEL: | N.E. |
Inhalation LC50: | >2000 ppm/4 hr (rat); >1800 ppm/6 hr (monkey) practically | STEL: | N.E. |
Eye Irritation: | May cause irritation. | Ceiling: | N.E. |
Skin Sensitization: | Not a sensitizer. | XEL4: | 200 ppm (isoparaffinic |
Skin Irritation: | Not an irritant. |
| hydrocarbon solvent) |
Human Patch: | |||
Mutagenicity: | No mutagenicity detected in Ames, Pol | ||
Carcinogens: | Exchange, Dominant Lethal and Micronucleus Assays. |
|
|
None present |
|
| |
Aquatic LC50: | None available |
|
|
Additional Information:
•Isoparaffinic hydrocarbon solvent has a low order of acute oral and dermal toxicity, but minute amounts aspirated into the lungs during ingestion or vomiting may cause mild to severe pulmonary injury, including fatality.
•Rat inhalation at 900 ppm not fetotoxic or teratogenic.
1The product does not contain a toxic chemical(s) subject to the reporting requirements of Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 and 40CFR Part 372. Its ingredients do not appear on the California Proposition 65 List. 2All ingredients contained within this product are listed on the Canadian Domestic Substances List (DSL) 3These ingredients are claimed as a trade secret by a Xerox supplier. They are registered in the following states under the respective trade secret numbers: Massachusetts,
N.A. - Not Applicable N.E. | 600E30170 |